101 related articles for article (PubMed ID: 24881576)
1. Central serotonergic neuron deficiency in a mouse model of Zellweger syndrome.
Rahim RS; Meedeniya AC; Crane DI
Neuroscience; 2014 Aug; 274():229-41. PubMed ID: 24881576
[TBL] [Abstract][Full Text] [Related]
2. PEX13 deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress.
Müller CC; Nguyen TH; Ahlemeyer B; Meshram M; Santrampurwala N; Cao S; Sharp P; Fietz PB; Baumgart-Vogt E; Crane DI
Dis Model Mech; 2011 Jan; 4(1):104-19. PubMed ID: 20959636
[TBL] [Abstract][Full Text] [Related]
3. Impaired neurogenesis and associated gliosis in mouse brain with PEX13 deficiency.
Rahim RS; St John JA; Crane DI; Meedeniya ACB
Mol Cell Neurosci; 2018 Apr; 88():16-32. PubMed ID: 29187321
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial changes and oxidative stress in a mouse model of Zellweger syndrome neuropathogenesis.
Rahim RS; Chen M; Nourse CC; Meedeniya AC; Crane DI
Neuroscience; 2016 Oct; 334():201-213. PubMed ID: 27514574
[TBL] [Abstract][Full Text] [Related]
5. Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype.
Maxwell M; Bjorkman J; Nguyen T; Sharp P; Finnie J; Paterson C; Tonks I; Paton BC; Kay GF; Crane DI
Mol Cell Biol; 2003 Aug; 23(16):5947-57. PubMed ID: 12897163
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of PEX13 mutation in a Zellweger syndrome spectrum patient reveals novel homooligomerization of PEX13 and its role in human peroxisome biogenesis.
Krause C; Rosewich H; Woehler A; Gärtner J
Hum Mol Genet; 2013 Oct; 22(19):3844-57. PubMed ID: 23716570
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the neuropathogenesis of Zellweger syndrome.
Crane DI
Neurochem Int; 2014 Apr; 69():1-8. PubMed ID: 24607700
[TBL] [Abstract][Full Text] [Related]
8. Failure of microtubule-mediated peroxisome division and trafficking in disorders with reduced peroxisome abundance.
Nguyen T; Bjorkman J; Paton BC; Crane DI
J Cell Sci; 2006 Feb; 119(Pt 4):636-45. PubMed ID: 16449325
[TBL] [Abstract][Full Text] [Related]
9. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation.
Migliarini S; Pacini G; Pelosi B; Lunardi G; Pasqualetti M
Mol Psychiatry; 2013 Oct; 18(10):1106-18. PubMed ID: 23007167
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome deficient PEX2 Zellweger mouse: pathologic and biochemical correlates of lipid dysfunction.
Faust PL; Su HM; Moser A; Moser HW
J Mol Neurosci; 2001; 16(2-3):289-97; discussion 317-21. PubMed ID: 11478384
[TBL] [Abstract][Full Text] [Related]
11. Abnormal cerebellar histogenesis in PEX2 Zellweger mice reflects multiple neuronal defects induced by peroxisome deficiency.
Faust PL
J Comp Neurol; 2003 Jun; 461(3):394-413. PubMed ID: 12746876
[TBL] [Abstract][Full Text] [Related]
12. PEX11 beta deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function.
Li X; Baumgart E; Morrell JC; Jimenez-Sanchez G; Valle D; Gould SJ
Mol Cell Biol; 2002 Jun; 22(12):4358-65. PubMed ID: 12024045
[TBL] [Abstract][Full Text] [Related]
13. Drosophila carrying pex3 or pex16 mutations are models of Zellweger syndrome that reflect its symptoms associated with the absence of peroxisomes.
Nakayama M; Sato H; Okuda T; Fujisawa N; Kono N; Arai H; Suzuki E; Umeda M; Ishikawa HO; Matsuno K
PLoS One; 2011; 6(8):e22984. PubMed ID: 21826223
[TBL] [Abstract][Full Text] [Related]
14. Peroxisomal protein PEX13 functions in selective autophagy.
Lee MY; Sumpter R; Zou Z; Sirasanagandla S; Wei Y; Mishra P; Rosewich H; Crane DI; Levine B
EMBO Rep; 2017 Jan; 18(1):48-60. PubMed ID: 27827795
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse).
Baumgart E; Vanhorebeek I; Grabenbauer M; Borgers M; Declercq PE; Fahimi HD; Baes M
Am J Pathol; 2001 Oct; 159(4):1477-94. PubMed ID: 11583975
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients.
Krause C; Rosewich H; Thanos M; Gärtner J
Hum Mutat; 2006 Nov; 27(11):1157. PubMed ID: 17041890
[TBL] [Abstract][Full Text] [Related]
17. Zellweger syndrome - a lethal peroxisome biogenesis disorder.
Rafique M; Zia S; Rana MN; Mostafa OA
J Pediatr Endocrinol Metab; 2013; 26(3-4):377-9. PubMed ID: 23327810
[TBL] [Abstract][Full Text] [Related]
18. Zellweger syndrome caused by PEX13 deficiency: report of two novel mutations.
Al-Dirbashi OY; Shaheen R; Al-Sayed M; Al-Dosari M; Makhseed N; Abu Safieh L; Santa T; Meyer BF; Shimozawa N; Alkuraya FS
Am J Med Genet A; 2009 Jun; 149A(6):1219-23. PubMed ID: 19449432
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system via the diazepam binding inhibitor.
Breitling R
BMC Pediatr; 2004 Mar; 4():5. PubMed ID: 15102341
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders.
Borgia P; Baldassari S; Pedemonte N; Alkhunaizi E; D'Onofrio G; Tortora D; Calì E; Scudieri P; Balagura G; Musante I; Diana MC; Pedemonte M; Vari MS; Iacomino M; Riva A; Chimenz R; Mangano GD; Mohammadi MH; Toosi MB; Ashrafzadeh F; Imannezhad S; Karimiani EG; Accogli A; Schiaffino MC; Maghnie M; Soler MA; Echiverri K; Abrams CK; Striano P; Fortuna S; Maroofian R; Houlden H; Zara F; Fiorillo C; Salpietro V
Orphanet J Rare Dis; 2022 Jul; 17(1):286. PubMed ID: 35854306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
